Multiple Co-primary Endpoints: Medical and Statistical Solutions: A Report from the Multiple Endpoints Expert Team of the Pharmaceutical Research and Manufacturers of America
Authors:
- 1 January 2007
- journal article
- other
- Published by Springer Nature in Drug Information Journal
- Vol. 41 (1) , 31-46
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Type I Error and Power in Noninferiority/Equivalence Trials with Correlated Multiple Endpoints: An Example from Vaccine Development TrialsJournal of Biopharmaceutical Statistics, 2004
- Lessons Learned From Recent Cardiovascular Clinical Trials: Part ICirculation, 2002
- Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololThe Lancet, 2002
- Considerations in the Evaluation of Surrogate Endpoints in Clinical TrialsControlled Clinical Trials, 2001
- Guidelines for Controlled Trials of Drugs in Migraine: Second EditionCephalalgia, 2000
- Migraine Therapy: Development and Testing of a Patient Preference QuestionnaireHeadache: The Journal of Head and Face Pain, 1998
- Some comments on frequently used multiple endpoint adjustment methods in clinical trialsStatistics in Medicine, 1997
- Multiple Comparisons1996
- Evaluating the efficacy of a combination therapyStatistics in Medicine, 1987
- Multiparameter Hypothesis Testing and Acceptance SamplingTechnometrics, 1982